Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Programmed Death-ligand 1 (PD-L1)
100%
Langerhans Cell Histiocytosis
100%
Erdheim-Chester Disease
100%
BRAF V600E
100%
Histiocytosis
100%
Histiocytic Sarcoma
75%
BRAF V600E mutation
50%
Follicular Dendritic Cell Sarcoma
50%
Immunohistochemical Analysis
25%
Disease Case
25%
Protein Expression
25%
In(III)
25%
Targeted Therapy
25%
Mutational Analysis
25%
Treatment Options
25%
Dendritic Cells
25%
Histiocytes
25%
Rare Tumors
25%
Rosai-Dorfman Disease
25%
MEK Inhibitor (MEKi)
25%
Inpatient Treatment
25%
Additional Treatment
25%
PTEN Protein
25%
Immune Checkpoint Molecules
25%
Gene Loss
25%
Histiocytic Disorders
25%
PTEN mutation
25%
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
25%
Tissue Infiltration
25%
SP142
25%
Immune Checkpoint Inhibitors
25%
Medicine and Dentistry
Biological Marker
100%
Histiocytosis
100%
Erdheim-Chester Disease
100%
Langerhans Cell Histiocytosis
100%
Programmed Death-Ligand 1
100%
Histiocytic Sarcoma
75%
Follicular Dendritic Cell Sarcoma
50%
Neoplasm
25%
Protein Expression
25%
Gene Mutation
25%
Targeted Therapy
25%
Dendritic Cell
25%
Rosai-Dorfman Disease
25%
Histiocyte
25%
Mutational Analysis
25%
MEK Inhibitor
25%
Rare Tumor
25%
Phosphatidylinositol 3,4,5 Trisphosphate 3 Phosphatase
25%
PTEN (Gene)
25%
Immune Checkpoint Inhibitor
25%
Plasmacytoid Dendritic Cell
25%
Gene Loss
25%
Diseases
25%
Treatment Option
25%
Veterinary Science and Veterinary Medicine
Langerhans Cell
100%
Erdheim-Chester Disease
100%
Histiocytic Sarcoma
75%
Follicular Dendritic Cell
50%
Diseases
50%
Connective Tissue Cancer
50%
Dendritic Cell
25%
Histiocyte
25%
Plasmacytoid Dendritic Cell
25%
Neoplasm
25%
Rare Tumor
25%